Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifeprunox in elderly subjects with psychosis and behavioral disturbances associated with Alzheimer's dementia
NCT00160147Phase 3Terminated
- Sponsor
- Solvay
- Start
- Dec 2005
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of bifeprunox in psychosis, behavioral disorders, sponsored by Solvay. Started Dec 2005; status: terminated.
02
Drugs
bifeprunox
03
Conditions
psychosisbehavioral disorders
Beyond the preview
Go deeper on NCT00160147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160147.